Castle biosciences inc.

View a summary page of this 2023 CONTRACT to CASTLE BIOSCIENCES, INC. from the Department of Veterans Affairs.Castle Biosciences, Inc. CSTL, a company improving health through innovative tests that guide patient care, today announced new data demonstrating the significant clinical utility of its ...SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 11/22/2023. 144/A. Amended report of proposed sale of securities. 11/22/2023. 4. Statement of Changes in Beneficial Ownership.Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm …Castle Biosciences created a tissue repository to enable all DecisionDx-UM patients to have access to their own tumor tissue for future use. This could include taking advantage of targeted treatments, clinical trials, and further prognostic testing as they become available. Castle Biosciences is a molecular diagnostics company that provides ...

Who can I contact if I have a question? Please call our customer service staff at 866-788-9007 or email [email protected]. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.

Apr 4, 2022 · Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. (AltheaDx). AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that ...

Castle Biosciences Inc’s price is currently down 25.04% so far this month. During the month of October, Castle Biosciences Inc’s stock price has reached a high of $16.84 and a low of $12.07. Over the last year, Castle Biosciences Inc has hit prices as high as $29.59 and as low as $9.26.JUST RELEASED: Castle Biosciences announces financial results for the 3rd quarter and nine months ended 9/30/23. Highlights: Q3 2023 revenue… Liked by Alissa HicksIf you're a new customer to Castle Biosciences, please call us when ordering a test. If a returning customer, you can use the requisition form. DOI: 10.1200/PO.20.00119 JCO Precision Oncology no. 5 (2021) 589-601. Published online April 6, 2021.

Revenue growth over the past 12 months for CASTLE BIOSCIENCES INC comes in at 55.17%, a number that bests 91.18% of the US stocks we're tracking. Stocks with similar financial metrics, market capitalization, and price volatility to CASTLE BIOSCIENCES INC are SILK, ONTF, IGC, FLGT, and BMRA. Visit CSTL's SEC page to see the company's …

View the latest Castle Biosciences Inc. (CSTL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Jun 23, 2019 · Our History. Castle Biosciences was founded by Derek Maetzold who believed that traditional methods to determine cancer patients’ prognosis could be improved by newly emerging techniques in molecular biology. We continue to focus on transforming disease management in areas of unmet clinical need through the development and marketing of ... Christopher Ballas is Chief Technology Officer at Castle Creek Biosciences, Inc. He has over 25 years of experience with cell and gene therapies in academic and industry roles covering research, development, testing, and manufacturing of viral vectors and cell therapies. Dr. Ballas recently was the Sr. Vice President of Manufacturing for Innovative …FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been selected ...C/O CASTLE BIOSCIENCES, INC. 505 S. FRIENDSWOOD DRIVE, SUITE 401 (Street) FRIENDSWOOD: TX: 77546 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol CASTLE BIOSCIENCES INC [ CSTL] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director:Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Castle Biosciences, Inc. Stock Symbol NASDAQ:CSTL. Company Type For Profit. Contact Email [email protected]. Phone Number 602-535-1997. Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer.

“Castle delivered a strong start to the year,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “Building on our strength and momentum from 2022, we delivered significant test report volume and revenue growth in the first quarter, which was driven by continued execution on our short- and long-term strategies.9 Nov 2023 ... Castle Biosciences Inc · View all. According to data from the RCT, IDgenetix-guided medication management showed a 37% improvement in response ...Castle Biosciences, Inc. | 10,149 followers on LinkedIn. Improving health through innovative tests that guide patient care | Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on transforming disease management by keeping people first—the patients who benefit from the information that our advanced diagnostic tests …FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced an independent, peer ...Nov 2, 2022 · Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.47 per share a year ago. Customer Service: 866-788-9007. CLINICIAN PORTAL. Customer Service: 866-788-9007

3 Castle Biosciences, Inc, Friendswood, Texas. 4 University of Rochester, Rochester, New York. 5 Icahn School of Medicine at Mount Sinai, New York, New York; Arkansas Dermatology Skin Cancer Center, Little Rock, Arkansas. 6 Oregon Health & Science University, Portland, Oregon.

FRIENDSWOOD, Texas, March 10, 2023--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new ...Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ... Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...Nov 24, 2023 · Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to ... Castle Biosciences - Unit 3 - Nova Place. of any of its obligations in this Lease contained unless and until Landlord shall have failed to perform such obligation within thirty (30) days, or such additional time as is reasonably required to correct any such default, after notice by Tenant to Landlord properly specifying wherein Landlord has ...Castle Biosciences, Inc. 19.85. +0.47. +2.43%. Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good afternoon and welcome to Castle Biosciences ...Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...Research and Development, Castle Biosciences, Inc, Friends-wood, Texas.f Funding sources: This work was funded by Castle Biosciences, Inc, United States. IRB approval status: Each cohort used in the analysis was under a protocol approved by an IRB. Accepted for publication June 26, 2022. Reprint requests: Matthew S. Goldberg, MD, …

Nov 2, 2022 · Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.47 per share a year ago.

2,091.70 +34.50(+1.68%) Castle Biosciences, Inc. (CSTL) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 19.97 -0.02 (-0.10%) At close: 04:00PM EST 20.35 +0.38 (+1.90%) After...

C/O CASTLE BIOSCIENCES, INC. 505 S. FRIENDSWOOD DRIVE, SUITE 401 (Street) FRIENDSWOOD: TX: 77546 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol CASTLE BIOSCIENCES INC [ CSTL] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director:In this line, the company recently divested its wholly-owned subsidiary -- Myriad myPath Melanoma, LLC to Castle Biosciences, Inc -- for a total value of $32.5 million in cash.Texas - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication …Contact Information. Customer Service: 866-788-9007 Option 1 [email protected]. Reimbursement: 866-788-9007 Option 3 [email protected] On April 12, 2023, Castle Biosciences, Inc. (“Castle”) filed a definitive proxy statement (the “Proxy Statement”) with the Securities and Exchange Commission in connection with its 2023 Annual Meeting of Stockholders to be held on May 25, 2023 (the “Annual Meeting”). On May 15, 2023, Castle issued the below letter to its stockholders.Nov 8, 2023 · By providing your email address below, you are providing consent to Castle Biosciences to send you the requested Investor Email Alert updates. * Required. Email Address*. Investor Alert Options*. News. Events & Presentations. Quarterly Reports. Annual Reports. SEC Filings. Who can I contact if I have a question? Please call our customer service staff at 866-788-9007 or email [email protected]. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes. Castle Biosciences, Inc. 820 S. Friendswood Drive, Suite 201 Friendswood, Texas 77546 (866) 788-9007 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: Thomas A. Coll, Esq. Karen E. Deschaine, Esq. Cooley LLP 4401 Eastgate MallCastle Biosciences Customer Service Email: [email protected] Call: (412) 820-3050 Billing and Insurance Questions Email: [email protected] Call: 866-788-9007, option #3 For additional information about Castle Biosciences or TissueCypher testing, please go to: …

THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of September 15, 2008 (the “Effective Date”) by and between Castle Biosciences, Inc., a Delaware corporation (the “Company”), and Kristen Oelschlager (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).Castle Biosciences Inc. May 2008 - Present15 years 7 months. Friendswood, Texas and Phoenix, Arizona. Castle Biosciences, Inc is a privately held, commercial stage molecular diagnostics company ...Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Vice President, Investor Relations & Corporate Affairs. See full bio. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.Instagram:https://instagram. disney investorspxystwtrsummary apple event JUST RELEASED: Castle Biosciences announces financial results for the 3rd quarter and nine months ended 9/30/23. Highlights: Q3 2023 revenue… Liked by Alissa HicksCastle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that data spanning its dermatologic portfolio of gene expression profile (GEP) tests was recently presented at the 2023 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago. are there brokers for cryptocurrencycollateralized loan obligation etf Nov 8, 2023 · By providing your email address below, you are providing consent to Castle Biosciences to send you the requested Investor Email Alert updates. * Required. Email Address*. Investor Alert Options*. News. Events & Presentations. Quarterly Reports. Annual Reports. SEC Filings. compose trade 1 Jun 2023 ... NEW YORK – Medicare Administrative Contractor Wisconsin Physicians Service Insurance Corporation has released a proposed local coverage ...FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Centers for ...National award recognizes Castle’s strong culture and employee engagement. September 19, 2023 07:00 AM Eastern Daylight Time. FRIENDSWOOD, Texas-- ( BUSINESS WIRE )--Castle Biosciences, Inc ...